Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

AXGN - Axogen Inc.


IEX Last Trade
13.18
0.190   1.442%

Share volume: 277,735
Last Updated: Fri 30 Aug 2024 09:59:55 PM CEST
Surgical and Medical Instrument Manufacturing : -0.56%

PREVIOUS CLOSE
CHG
CHG%

$12.99
0.19
1.46%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
15%
Profitability 18%
Dept financing 12%
Liquidity 71%
Performance 0%
Company vs Stock growth
vs
Performance
5 Days
5.03%
1 Month
49.77%
3 Months
87.86%
6 Months
27.30%
1 Year
105.79%
2 Year
42.16%
Key data
Stock price
$13.18
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
$0.00
52 WEEK RANGE
$3.45 - $13.20
52 WEEK CHANGE
$1.09
MARKET CAP 
576.362 M
YIELD 
N/A
SHARES OUTSTANDING 
43.830 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/05/2024
BETA 
1.98
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$304,815
AVERAGE 30 VOLUME 
$585,995
Company detail
CEO:
Region: US
Website: axogeninc.com
Employees: 418
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

it's time to rethink nerve repair! axogen (nasdaq: axgn) is a medical products company with a portfolio of proprietary products and technologies for peripheral nerve reconstruction and regeneration. people suffer traumatic injuries or undergo surgeries that impact the function of their peripheral nerves daily. damage may cause loss of function and feeling. axogen is bringing the science of nerve repair to life with its avance® nerve graft which axogen believes is the first and only commercially available allograft for bridging nerve discontinuities, axoguard® nerve connector, a coaptation aid allowing for close approximation of severed nerves, and axoguard® nerve protector that protects nerves during the healing process.

Recent news